A promising new drug may be responsible for some recent rapid recoveries in critically ill COVID-19 patients.  According to a report in Click2Houston, Houston Methodist Hospital has been administering a drug known as RLF-100 (aviptadil) to some of their COVID-19 patients on ventilators and with severe medical conditions.  Within 3-4 days, many of those patients came off the ventilators or showed other signs of recovery.

NeuroRX Inc. and Relief Therapeutics Holdings AG are the manufacturers of RLF-100 and there research team will be conducting more tests to confirm the drug's safety and effectiveness.

Enter your number to get our free mobile app

More From 92.9 The Lake